Akron City Hospital Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2006
NCT00365105
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Summa Center for Cancer Care at Akron City Hospital

Active Ingredients

Drugs in Phase 3 Trials (5)

153sm-edtmp (1 trial)

calcium (1 trial)

strontium-89 (1 trial)

vitamin d3 (1 trial)

zoledronic acid (zometa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Lung Neoplasms (Phase 3)

Neoplasm Metastasis (Phase 3)

Prostatic Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 5